DelMar Pharmaceuticals Appoints Biopharmaceutical Industry Veteran, Erich Mohr, Ph.D., R.Psych., to the Board of Directors Apr 1, 2015
DelMar Pharmaceuticals Receives Notice of Allowance of Fourth U.S. Patent Covering Methods of Use and Compositions for VAL-083 Mar 2, 2015
DelMar Pharmaceuticals to Present Clinical and Preclinical Abstracts for VAL-083 at the American Association of Cancer Research (AACR) Annual Meeting in April 2015 Feb 24, 2015
DelMar Pharmaceuticals Announces December 31, 2014 Financial Results and Provides Corporate Update Feb 12, 2015
DelMar Pharmaceuticals Appoints Lynda Cranston, BScN, MScN, ICD.D, to the Board of Directors Feb 11, 2015
DelMar Pharmaceuticals Completes Offer to Exchange Common Stock for Outstanding Warrants Feb 10, 2015
DelMar Pharmaceuticals Provides Update on VAL-083 Clinical Trial and Outlines Corporate Objectives for 2015 Jan 12, 2015
